Bryce Olson, Intel Global Marketing Director, Health and Life Sciences and stage 4 cancer survivor, set out to find better treatment for his illness through technology. Bryce, Intel and the cancer center at Oregon Health & Science University (OHSU) utilized genomics data and precision medicine driven by AI technology revealing Olson’s disease was fueled by a mutated pathway deep in his DNA. By using AI to sift through his data as well as millions of other patients with a similar condition, clinical trial testing identified a new inhibitor of the mutated pathway. Olson underwent treatment based on this discovery and is now in remission.
About Intel
Intel, the world leader in silicon innovation, develops technologies, products and initiatives to continually advance how people work and live. Founded in 1968 to build semiconductor memory products, Intel introduced the world’s first microprocessor in 1971. This decade, our mission is to create and extend computing technology to connect and enrich the lives of every person on earth.
Sign up for the free insideBIGDATA newsletter.
Speak Your Mind